What is the price-to-earnings ratio of Rigel Pharmaceuticals?
The price-earnings ratio of Rigel Pharmaceuticals is currently 1.07.
Rigel Pharmaceuticals P/S 2024
Rigel Pharmaceuticals P/S
1.07
Ticker
RIGL
ISIN
US7665596034
WKN
766093
As of Sep 29, 2024, Rigel Pharmaceuticals's P/S ratio stood at 1.07, a -48.56% change from the 2.08 P/S ratio recorded in the previous year.
The Rigel Pharmaceuticals P/S history
Rigel Pharmaceuticals Aktienanalyse
What does Rigel Pharmaceuticals do?
Rigel Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of drugs for the treatment of autoimmune diseases, inflammation, and cancer. It was founded in 1996 by Donald Payan. The company is headquartered in South San Francisco, California. Rigel Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Rigel Pharmaceuticals's P/S Ratio
Rigel Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Rigel Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Rigel Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Rigel Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Rigel Pharmaceuticals stock
How has the price-earnings ratio of Rigel Pharmaceuticals changed compared to last year?
The price-to-earnings ratio of Rigel Pharmaceuticals has increased by -48.56% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Rigel Pharmaceuticals high compared to other companies?
Yes, the price-to-earnings ratio of Rigel Pharmaceuticals is high compared to other companies.
How does an increase in the price-earnings ratio of Rigel Pharmaceuticals affect the company?
An increase in the price-earnings ratio of Rigel Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Rigel Pharmaceuticals affect the company?
A decrease in the price-earnings ratio of Rigel Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Rigel Pharmaceuticals?
Some factors that influence the price-earnings ratio of Rigel Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Rigel Pharmaceuticals pay?
Over the past 12 months, Rigel Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rigel Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Rigel Pharmaceuticals?
The current dividend yield of Rigel Pharmaceuticals is .
When does Rigel Pharmaceuticals pay dividends?
Rigel Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Rigel Pharmaceuticals?
Rigel Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Rigel Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Rigel Pharmaceuticals located?
Rigel Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Rigel Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Rigel Pharmaceuticals from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.
When did Rigel Pharmaceuticals pay the last dividend?
The last dividend was paid out on 9/29/2024.
What was the dividend of Rigel Pharmaceuticals in the year 2023?
In the year 2023, Rigel Pharmaceuticals distributed 0 USD as dividends.
In which currency does Rigel Pharmaceuticals pay out the dividend?
The dividends of Rigel Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Rigel Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Rigel Pharmaceuticals
Our stock analysis for Rigel Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rigel Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Rigel Pharmaceuticals Revenue
- Rigel Pharmaceuticals Net Income
- Rigel Pharmaceuticals P/E
- Rigel Pharmaceuticals P/S
- Rigel Pharmaceuticals EBIT
- Rigel Pharmaceuticals Dividend
- Rigel Pharmaceuticals Stocks
- Rigel Pharmaceuticals Market capitalization
- Rigel Pharmaceuticals Debt
- Rigel Pharmaceuticals Liabilities
- Rigel Pharmaceuticals Equity
- Rigel Pharmaceuticals AAQS
- Rigel Pharmaceuticals Employees
- Rigel Pharmaceuticals ROE
- Rigel Pharmaceuticals ROA
- Rigel Pharmaceuticals ROCE
